Gushengtang Holdings Ltd
HKEX:2273
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
33.25
51.35
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Gushengtang Holdings Ltd
Cost of Revenue
Gushengtang Holdings Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Gushengtang Holdings Ltd
HKEX:2273
|
Cost of Revenue
-¥1.6B
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
|
Cost of Revenue
-¥5.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Topchoice Medical Co Inc
SSE:600763
|
Cost of Revenue
-¥1.8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-19%
|
|
|
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
|
Cost of Revenue
-¥3.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-3%
|
|
|
Dian Diagnostics Group Co Ltd
SZSE:300244
|
Cost of Revenue
-¥9B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-27%
|
|
|
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
|
Cost of Revenue
-¥6.2B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-24%
|
|
Gushengtang Holdings Ltd
Glance View
Gushengtang Holdings Ltd. operates the neo-TCM primary care platform, which combines inviting in-person care and seamless digital health powered by internet and AI technologies. The company is headquartered in Guangzhou, Guangdong. The company went IPO on 2021-12-10. The firm operates in two segments. Medical and Health Solutions segment is engaged in providing customers with traditional Chinese medical and health services through offline medical institutions and online medical and health platforms, including consultation, diagnosis, prescription services, decoctions and physical therapy. Sales of Medical and Health Products segment is mainly responsible for the sales of related products. The firm's main products include Ejiao, Cordyceps, cubilose, dendrobium, American Ginseng and other medicinal materials. The firm also provides honey, Ejiao cake and other nutritional products.
See Also
What is Gushengtang Holdings Ltd's Cost of Revenue?
Cost of Revenue
-1.6B
CNY
Based on the financial report for Dec 31, 2023, Gushengtang Holdings Ltd's Cost of Revenue amounts to -1.6B CNY.
What is Gushengtang Holdings Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-30%
Over the last year, the Cost of Revenue growth was -44%. The average annual Cost of Revenue growth rates for Gushengtang Holdings Ltd have been -49% over the past three years , -30% over the past five years .
You don't have any saved screeners yet
